Reino Unido -
inglés -
MHRA (Medicines & Healthcare Products Regulatory Agency)
magnevist 0.5mmol/ml solution for injection 20ml pre-filled syringes
bayer plc - meglumine gadopentetate - solution for injection - .5mmol/1ml
Reino Unido -
inglés -
MHRA (Medicines & Healthcare Products Regulatory Agency)
magnevist 0.5mmol/ml solution for injection 20ml vials
bayer plc - meglumine gadopentetate - solution for injection - .5mmol/1ml
Reino Unido -
inglés -
MHRA (Medicines & Healthcare Products Regulatory Agency)
magnevist 0.5mmol/ml solution for injection 5ml vials
bayer plc - meglumine gadopentetate - solution for injection - .5mmol/1ml
Armenia -
inglés -
Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
megaray inj.
dongkook pharmaceutical co. - gadopentetic acid (meglumine gadopentetate) - solution for injection - 469,01mg/ml
Singapur -
inglés -
HSA (Health Sciences Authority)
multihance injection 15 ml
dch auriga singapore - gadobenate dimeglumine - injection - 529 mg/ml - gadobenate dimeglumine 529 mg/ml
Singapur -
inglés -
HSA (Health Sciences Authority)
multihance injection 20 ml
dch auriga singapore - gadobenate dimeglumine - injection - 529 mg/ml - gadobenate dimeglumine 529 mg/ml
Irlanda -
inglés -
HPRA (Health Products Regulatory Authority)
multihance 529 mg/ml solution for injection
bracco spa - gadobenate dimeglumine - solution for injection - 529 mg/ml
Irlanda -
inglés -
HPRA (Health Products Regulatory Authority)
multihance 0.5m micromol solution for injection
bracco spa - gadobenate dimeglumine - solution for injection - 0.5m micromol
Israel -
inglés -
Ministry of Health
multihance
dexcel ltd, israel - gadobenic acid as dimeglumine salt - solution for injection - gadobenic acid as dimeglumine salt 334 mg/ml - gadobenic acid - gadobenic acid - multihance is a paramagnetic contrast agent for use in diagnostic magnetic resonance imaging (mri) indicated for: • mri of the liver for the detection of focal liver lesions in patients with known or suspected primary liver cancer (eg. hepatocellular carcinoma) or metastatic disease.• mri of the brain and spine where it improves the detection of lesions and provides diagnostic information additional to that obtained with unenhanced mri.• contrast-enhanced mr- angiography where it improves the diagnostic accuracy for detecting clinically significant steno-occlusive vascular disease in patients with suspected or known vascular disease of the abdominal or peripheral arteries.• mri of the breast, for the detection of malignant lesions in patients where breast cancer is known or suspected on the basis of previous mammography or ultrasound results
Reino Unido -
inglés -
MHRA (Medicines & Healthcare Products Regulatory Agency)
magnevist 2mmol/litre solution for injection 20ml pre-filled syringes
bayer plc - meglumine gadopentetate - solution for injection - .002mmol/1ml